Turn Therapeutics Inc. Common Stock (NASDAQ: TTRX) last traded at $11.53, down 3.92% on the session. The quote above updates while this page is open; the figures below are drawn from Turn Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Turn Therapeutics Inc. Common Stock trades on NASDAQ under the ticker TTRX. Its market capitalisation is $343.46 million.
Valuation measures for Turn Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $343.46M |
|---|---|
| Enterprise value | $349.78M |
| Price / book | 500.02 |
| Beta | 1.21 |
Trailing-twelve-month figures tagged in Turn Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$8.45M |
| EPS (TTM) | -$0.290 |
|---|
| Return on equity | -1229.58% |
|---|
| Cash | $9.95M |
|---|
Range and volume for TTRX over the past 52 weeks.
| 52-week high | $16.45 |
|---|---|
| 52-week low | $2.57 |
| Volume | 13.8K |
| Average volume | 108.1K |
| Previous close | $12.00 |
Invest a chosen dollar amount in Turn Therapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TTRX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.